Zobrazeno 1 - 10 of 60 pro vyhledávání: '"Goepfert RP"'
2
Akademický článek
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma.
Autor: Keatts SA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salem AF; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Swanson DM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Farooqi AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Weiser R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ashleigh Guadagnolo B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mitra D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2024 Sep 11; Vol. 49, pp. 100856. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation.
Autor: Sahin O; The University of Texas MD Anderson Cancer Center, Houston, USA., Kamel S; The University of Texas MD Anderson Cancer Center, Houston, USA., Wahid KA; The University of Texas MD Anderson Cancer Center, Houston, USA., Dede C; The University of Texas MD Anderson Cancer Center, Houston, USA., Taku N; The University of Texas MD Anderson Cancer Center, Houston, USA., He R; The University of Texas MD Anderson Cancer Center, Houston, USA., Naser MA; The University of Texas MD Anderson Cancer Center, Houston, USA., Sharafi S; The University of Texas MD Anderson Cancer Center, Houston, USA., Mäkitie A; University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kann BH; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Kaski K; Aalto University, Espoo, Finland., Sahlsten J; Aalto University, Espoo, Finland., Jaskari J; Aalto University, Espoo, Finland., Amit M; The University of Texas MD Anderson Cancer Center, Houston, USA., Chronowski GM; The University of Texas MD Anderson Cancer Center, Houston, USA., Diaz EM Jr; The University of Texas MD Anderson Cancer Center, Houston, USA., Garden AS; The University of Texas MD Anderson Cancer Center, Houston, USA., Goepfert RP; The University of Texas MD Anderson Cancer Center, Houston, USA., Guenette JP; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Gunn GB; The University of Texas MD Anderson Cancer Center, Houston, USA., Hirvonen J; Tampere University, Faculty of Medicine and Health Technology and Tampere University Hospital, Tampere, Finland., Hoebers F; Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Hutcheson KA; The University of Texas MD Anderson Cancer Center, Houston, USA., Guha-Thakurta N; The University of Texas MD Anderson Cancer Center, Houston, USA., Johnson J; The University of Texas MD Anderson Cancer Center, Houston, USA., Kaya D; The University of Texas MD Anderson Cancer Center, Houston, USA., Khanpara SD; The University of Texas MD Anderson Cancer Center, Houston, USA., Nyman K; University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Lai SY; The University of Texas MD Anderson Cancer Center, Houston, USA., Lango M; The University of Texas MD Anderson Cancer Center, Houston, USA., Learned KO; The University of Texas MD Anderson Cancer Center, Houston, USA., Lee A; The University of Texas MD Anderson Cancer Center, Houston, USA., Lewis CM; The University of Texas MD Anderson Cancer Center, Houston, USA., Maniakas A; The University of Texas MD Anderson Cancer Center, Houston, USA., Moreno AC; The University of Texas MD Anderson Cancer Center, Houston, USA., Myers JN; The University of Texas MD Anderson Cancer Center, Houston, USA., Phan J; The University of Texas MD Anderson Cancer Center, Houston, USA., Pytynia KB; The University of Texas MD Anderson Cancer Center, Houston, USA., Rosenthal DI; The University of Texas MD Anderson Cancer Center, Houston, USA., Sandulache VC; Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, USA., Schellingerhout D; The University of Texas MD Anderson Cancer Center, Houston, USA., Shah SJ; The University of Texas MD Anderson Cancer Center, Houston, USA., Sikora AG; The University of Texas MD Anderson Cancer Center, Houston, USA., Mohamed ASR; The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, USA., Chen MM; The University of Texas MD Anderson Cancer Center, Houston, USA., Fuller CD; The University of Texas MD Anderson Cancer Center, Houston, USA.
Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Jun 08. Date of Electronic Publication: 2024 Jun 08.
Zobrazit plný text záznamu
4
Akademický článek
Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes.
Autor: Cass S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Cope B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Chiang YJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Ashleigh Guadagnolo B; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Farooqi A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Morrison W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Seervai RNH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, United States., Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Ross M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Wong M; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Mitra D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States. Electronic address: dmitra@mdanderson.org.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Nov; Vol. 188, pp. 109892. Date of Electronic Publication: 2023 Sep 01.
Zobrazit plný text záznamu
5
Akademický článek
Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer.
Autor: Dohopolski MJ; Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas., Diao K; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Hutcheson KA; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas., Akhave NS; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas., Goepfert RP; Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas., He W; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Lei XJ; Department of Health Services Research, MD Anderson Cancer Center, Houston, Texas., Peterson SK; Department of Behavioral Science, MD Anderson Cancer Center, Houston, Texas., Shen Y; Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas., Sumer BD; Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas., Smith BD; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Sher DJ; Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas.
Publikováno v: JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2023 Aug 01; Vol. 149 (8), pp. 697-707.
Zobrazit plný text záznamu
6
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.
Autor: Baruch EN; Division of Cancer Medicine, Hematology and Oncology Fellowship program, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nagarajan P; Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gleber-Netto FO; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rao X; Department of Bioinformatics and Computational Biology, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xie T; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Akhter S; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adewale A; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shajedul I; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mattson BJ; The Neurodegeneration Consortium, Therapeutics Discovery Division, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ferrarotto R; Department of Head and Neck Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong MK; Department of Melanoma Medical Oncology, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jindal S; Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Basu S; Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Harwood C; Department of Dermatology, Royal London Hospital, Barts Health NHS Trust, Centre for Cell Biology and Cutaneous Research, Blizard Institute Barts and the London School of Medicine and Dentistry Queen Mary University of London, UK., Leigh I; Department of Dermatology, Royal London Hospital, Barts Health NHS Trust, Centre for Cell Biology and Cutaneous Research, Blizard Institute Barts and the London School of Medicine and Dentistry Queen Mary University of London, UK., Ajami N; Department of Genomic Medicine, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal A; Department of Genomic Medicine, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Castillo M; Department of Biology and Biochemistry, University of Houston Sequencing and Gene Editing Core, University of Houston, Houston, TX, USA., Gunaratne P; Department of Biology and Biochemistry, University of Houston Sequencing and Gene Editing Core, University of Houston, Houston, TX, USA., Goepfert RP; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khushalani N; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL, USA., Wang J; Department of Bioinformatics and Computational Biology, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Watowich S; Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Calin GA; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Migden MR; Department of Dermatology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vermeer P; Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, SD, USA., D'Silva N; Department of Dentistry & Pathology, the University of Michigan, Ann Arbor, MI, USA., Yaniv D; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Burks JK; Department of Leukemia, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gomez J; Department of Leukemia, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dougherty PM; Department of Pain Medicine, Division of Anesthesiology, Critical Care, and Pain Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tsai KY; Department of Tumor Biology, Moffitt Cancer Center, Tampa, FL, USA., Allison JP; Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo J; Department of Genomic Medicine, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Myers JN; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gross ND; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amit M; Department of Head and Neck Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX.
Publikováno v: Research square [Res Sq] 2023 Jul 18. Date of Electronic Publication: 2023 Jul 18.
Zobrazit plný text záznamu
7
Akademický článek
Impact of Cancer Care Regionalization on Patient Volume.
Autor: Contrera KJ; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tam S; Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health System, Detroit, MI, USA., Pytynia K; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diaz EM Jr; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lango M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weber RS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eguia A; Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA., Pisters PWT; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adair DK; Department of Global Business Development, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nair AS; Department of Global Business Development, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mayo L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chronowski GM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zafereo ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mzafereo@mdanderson.org., Shah SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2023 Apr; Vol. 30 (4), pp. 2331-2338. Date of Electronic Publication: 2022 Dec 29.
Zobrazit plný text záznamu
8
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Autor: Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rnamaria@mdanderson.org., Postow M; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Burton EM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of California San Francisco, San Francisco, CA, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Torres-Cabala C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duan F; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Busam K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Simpson L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Betof-Warner A; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Shoushtari AN; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Callahan M; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Coit D; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bartlett EK; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bello D; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Momtaz P; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Nicholas C; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gu A; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang X; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Korivi BR; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patnana M; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Ariyan C; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v: Nature [Nature] 2023 Mar; Vol. 615 (7953), pp. E23.
Zobrazit plný text záznamu
9
Akademický článek
Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
Autor: Hemmati M; Computational Applied Mathematics and Operations Research, William Marsh Rice University, Houston, Texas, USA., Barbon C; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA., van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology, University Medical Center- Groningen, Groningen, Netherlands., Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gross ND; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA., Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA., Schaefer AJ; Computational Applied Mathematics and Operations Research, William Marsh Rice University, Houston, Texas, USA., Fuller CD; Computational Applied Mathematics and Operations Research, William Marsh Rice University, Houston, Texas, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.
Publikováno v: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 5088-5098. Date of Electronic Publication: 2022 Oct 13.
Zobrazit plný text záznamu
10
Akademický článek
Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors.
Autor: Aggarwal P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nader ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gidley PW; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pratihar R; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jivani S; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mott FE; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ogboe CW; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Charles C; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA., Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shete S; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v: Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 569-583. Date of Electronic Publication: 2022 Jun 13.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje